[HTML][HTML] Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Background Recognizing the rapidly increasing interest and evidence in using metastasis-
directed radiotherapy (MDRT) for oligometastatic disease (OMD), ESTRO and ASTRO …
directed radiotherapy (MDRT) for oligometastatic disease (OMD), ESTRO and ASTRO …
Oligometastases: emerging evidence
The hypothesis that ablative therapies (such as surgery or radiation) can be used to cure
patients with a limited number of metastases was influential in changing practice. Early …
patients with a limited number of metastases was influential in changing practice. Early …
A review of ongoing trials of stereotactic ablative radiotherapy for oligometastatic cancers: Where will the evidence lead?
Purpose: The oligometastatic state is a proposed entity between localized cancer and widely
metastatic disease, comprising an intermediate subset of metastatic cancer patients. Most …
metastatic disease, comprising an intermediate subset of metastatic cancer patients. Most …
[HTML][HTML] Oligometastatic cancer: key concepts and research opportunities for 2021 and beyond
P Szturz, JB Vermorken - Cancers, 2021 - mdpi.com
Traditionally, clinicians distinguished three forms of cancer outgrowth. Classification in early,
locally or locoregionally advanced, and metastatic disease had purposefully reflected …
locally or locoregionally advanced, and metastatic disease had purposefully reflected …
Distant metastasis velocity as a novel prognostic score for overall survival after disease progression following stereotactic body radiation therapy for oligometastatic …
Purpose In patients with extracranial oligometastatic disease, distant failure (DF) after local
ablative therapies is common. Prognostic scores to guide salvage treatment decision …
ablative therapies is common. Prognostic scores to guide salvage treatment decision …
Management of oligo-metastatic and oligo-recurrent cervical cancer: a pattern of care survey within the EMBRACE research network
Background In the metastatic or recurrent cervical cancer, systemic chemotherapy
constitutes the main treatment. Though there is an increasing use of high dose external …
constitutes the main treatment. Though there is an increasing use of high dose external …
The road to dissemination: the concept of Oligometastases and the barriers for widespread disease
Simple Summary Oligometastatic disease is an intermediate state of metastatic
dissemination with a limited number of metastatic sites and extent of disease. Tumor cells …
dissemination with a limited number of metastatic sites and extent of disease. Tumor cells …
A risk stratification scheme for synchronous oligometastatic non-small cell lung cancer developed by a multicentre analysis
L Spaggiari, L Bertolaccini, F Facciolo, FT Gallina… - Lung Cancer, 2021 - Elsevier
Abstract Backgrounds Oligometastatic Non-Small Cell Lung Cancer (NSCLC) patients
represent a category without a standard therapeutic approach. However, in selected …
represent a category without a standard therapeutic approach. However, in selected …
The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study
X Huang, J Cui, X Li, C Liu, J Sun, J Yue - World Journal of Surgical …, 2021 - Springer
Background Inflammation markers have an important effect on tumor proliferation, invasion,
and metastasis. Oligometastatic disease (OMD) is an intermediate state between …
and metastasis. Oligometastatic disease (OMD) is an intermediate state between …
Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study
M Stefanovic, G Calvet, H Pérez-Montero… - Clinical and …, 2023 - Springer
Purpose Stereotactic body radiation therapy (SBRT) is a treatment modality with curative
intent for oligometastatic cancer patients, commonly defined by a low-burden metastatic …
intent for oligometastatic cancer patients, commonly defined by a low-burden metastatic …